Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

U.S. Rep. John Conyers, D-Mich. Photo: Carlos Osorio / AP

Rep. John Conyers of Michigan will not resign, his attorney announced at a press conference in Detroit today. "That decision sure as hell isn't up to [Nancy] Pelosi," he said. "She is jumping on the bandwagon now."

Why it matters: House Minority Leader Nancy Pelosi called for Conyers' resignation just moments before the press conference started, which comes after several women, including two of his former staffers, accused him of sexual harassment.

More from Conyers' attorney: "At the end of the day, I will suspect that Nancy Pelosi is going to have to explain what is the discernible difference between Al Franken and John Conyers," he said. "And again, he is not going to be pressured by Nancy Pelosi or anyone else. The decision will be made by Congressman Conyers as to what his next course of action is. That will not be today, that will not be tomorrow."

Go deeper: Conyers had previously stepped down from his his position as ranking member on the House Judiciary Committee while an ethics investigation takes place. And he admitted to paying a settlement to a former staffer, but denied the allegations.

Go deeper

Updated 43 mins ago - Health

FDA analysis finds Johnson & Johnson COVID vaccine is safe and effective

Photo: Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration's staff released a briefing document on Wednesday endorsing Johnson & Johnson's one-shot coronavirus vaccine as safe and effective.

The latest: Assuming the FDA issues an emergency use authorization "without delay," meaning as soon as this weekend, White House coronavirus coordinator Jeff Zients said J&J will have 3 million to 4 million ready for distribution next week.

Dan Primack, author of Pro Rata
2 hours ago - Economy & Business

LinkedIn co-founder's SPAC bets on flying taxis

Illustration: Aïda Amer/Axios

Reid Hoffman knows he isn't the first person who comes to mind when you hear "flying taxis."

Yes, but: The LinkedIn co-founder and venture capitalist insists that his latest deal is more than SPAC silliness, and that its success will be heavily reliant on the sorts of network effects that are in his historical wheelhouse.

2 hours ago - World

Scoop: U.S. and Israel to convene strategic forum on Iran

Biden and Netanyahu in Jerusalem in 2016. Photo: Debbie Hill/AFP via Getty

The United States and Israel have elected to reconvene a strategic working group on Iran, with the first round of talks on intelligence surrounding the Iranian nuclear program expected in the coming days, Axios has learned.

Why it matters: President Biden and Israeli Prime Minister Benjamin Netanyahu have sharply contrasting views of the 2015 Iran nuclear deal, but the resumption of the working group is a signal that their governments are starting with a serious and professional dialogue rather than a political fight.